CRF to sponsor 8th International Conference on Cell Therapy for Cardiovascular Disease

NewsGuard 100/100 Score

Top scientists gather in New York City to present ground-breaking advances and pioneering innovations in cell-based therapies for cardiovascular diseases

WHAT:

The final agenda for the Eighth International Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://celltherapy.crf.org/conference/agenda.html. The conference, which will be held January 23-25, 2013, is the premier meeting dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

This year's conference will focus on pivotal preclinical and clinical studies on the path to commercialization, focusing on the status of molecular, cell, and tissue products, in addition to delivery systems.

WHY:

Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 12th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has realized many notable successes, as well as identified challenges that await the next round of clinical studies. Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.

Sessions will focus on:

  • Pre-Clinical and Clinical Trial Results
  • Clinical Methods: Biologics Delivery
  • Chronic Vascular Insufficiency
  • Heart Failure and Chronic Myocardial Disease
  • Macro and Micro Structure: Implications for Tissue Repair
  • Cell Therapy in South and Central America
  • Goals and Logistics for the Next Decade

WHO:

Course Director, Conference on Cell Therapy for Cardiovascular Disease
Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center New York, NY

Course Co-Directors
Jozef Bartunek, MD, PhD
Cardiovascular Center, OLV Hospital
Aalst, Belgium

Henricus J. Duckers, MD, PhD
Erasmus Medical Center
Rotterdam, The Netherlands

Amit Patel, MD, MS
University of Utah
Salt Lake City, UT

Marc S. Penn, MD, PhD
Summa Health System
Akron, OH

Gustav Steinhoff, MD, PhD
University of Rostock
Rostock, Germany

Gordana Vunjak-Novakovic, PhD
Columbia University Medical Center
New York, NY

Wojciech Wojakowski, MD, PhD
Third Division of Cardiology
Katowice, Poland

WHEN:

January 23-25, 2013

WHERE:

Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Stem cell therapy safe and potentially beneficial for spinal cord injury patients